Copyright
©The Author(s) 2022.
World J Gastrointest Surg. May 27, 2022; 14(5): 442-451
Published online May 27, 2022. doi: 10.4240/wjgs.v14.i5.442
Published online May 27, 2022. doi: 10.4240/wjgs.v14.i5.442
Table 2 Overall survival of the patients with mass-forming intrahepatic cholangiocarcinoma
| All (n = 68) | Surgery (n = 49) | Exploration (n = 19) | P value | |
| Follow-up (mo) | 1-82 | 3-82 | 1-57 | |
| Survival | < 0.001 | |||
| 1 yr | 66.5% | 93.5% | 5.3% | |
| 3 yr | 36.3% | 49.7% | 5.3% | |
| 5 yr | 9.3% | 14.4% | 0.00% |
- Citation: Feng J, Liang B, Zhang HY, Liu Z, Jiang K, Zhao XQ. Prognostic factors for patients with mass-forming intrahepatic cholangiocarcinoma: A case series of 68 patients. World J Gastrointest Surg 2022; 14(5): 442-451
- URL: https://www.wjgnet.com/1948-9366/full/v14/i5/442.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v14.i5.442